| Mineral absorption |
1.72 |
4.15e-1 |
48/60 (80%) |
TF;MT1G;MT1M;...
|
| Fanconi anemia pathway |
1.65 |
3.79e-1 |
36/54 (66.67%) |
FANCL;REV3L;FANCA;...
|
| Asthma |
1.65 |
2.62e-1 |
25/31 (80.65%) |
HLA-DQA1;HLA-DOB;FCER1G;...
|
| Taurine and hypotaurine metabolism |
1.54 |
4.44e-1 |
8/11 (72.73%) |
GAD1;ADO;CSAD
|
| Mucin type O-glycan biosynthesis |
1.53 |
3.93e-1 |
20/36 (55.56%) |
GALNT7;GCNT3;GALNT12;...
|
| Type I diabetes mellitus |
1.53 |
3.53e-1 |
38/43 (88.37%) |
HLA-DQA1;GAD1;PTPRN2;...
|
| Mismatch repair |
1.53 |
3.04e-1 |
22/23 (95.65%) |
PCNA;RFC5;RPA2;...
|
| Glycosaminoglycan biosynthesis |
1.48 |
3.77e-1 |
40/58 (68.97%) |
HS3ST1;CHST1;B4GALT4;...
|
| D-Glutamine and D-glutamate metabolism |
1.44 |
4.53e-1 |
5/5 (100%) |
DGLUCY;GLS;GLS2
|
| GABAergic synapse |
1.41 |
5.16e-1 |
76/89 (85.39%) |
SLC38A1;GABRP;GAD1;...
|
| Glutamatergic synapse |
1.41 |
4.71e-1 |
97/114 (85.09%) |
SLC38A1;SLC1A1;GNG7;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
1.41 |
4.32e-1 |
62/70 (88.57%) |
CXCL8;PAK1;PLCG2;...
|
| Caffeine metabolism |
1.41 |
4.11e-1 |
5/6 (83.33%) |
NAT2;XDH;CYP1A2
|
| Transcriptional misregulation in cancer |
1.40 |
4.21e-1 |
158/192 (82.29%) |
PROM1;CXCL8;TMPRSS2;...
|
| Retinol metabolism |
1.40 |
4.02e-1 |
41/68 (60.29%) |
DHRS9;ALDH1A1;ALDH1A3;...
|
| Pyrimidine metabolism |
1.39 |
3.92e-1 |
40/56 (71.43%) |
NT5E;RRM2;ENTPD1;...
|
| Salivary secretion |
1.38 |
3.94e-1 |
76/93 (81.72%) |
LYZ;CST3;KCNN4;...
|
| Antigen processing and presentation |
1.37 |
4.06e-1 |
60/78 (76.92%) |
CALR;HLA-DQA1;LGMN;...
|
| Cell cycle |
1.36 |
4.12e-1 |
110/124 (88.71%) |
SMC1A;WEE1;CDKN1A;...
|
| Phosphatidylinositol signaling system |
1.35 |
4.18e-1 |
82/97 (84.54%) |
CDS1;INPP4B;DGKA;...
|
| Allograft rejection |
1.34 |
4.35e-1 |
32/38 (84.21%) |
HLA-DQA1;HLA-DOB;CD40;...
|
| Intestinal immune network for IgA production |
1.34 |
4.18e-1 |
38/48 (79.17%) |
HLA-DQA1;HLA-DOB;CD40;...
|
| IL-17 signaling pathway |
1.31 |
4.80e-1 |
84/94 (89.36%) |
S100A8;S100A9;CXCL8;...
|
| Ferroptosis |
1.31 |
4.67e-1 |
36/41 (87.8%) |
TF;SLC39A8;ACSL5;...
|
| Vitamin digestion and absorption |
1.29 |
5.06e-1 |
17/24 (70.83%) |
SLC5A6;ABCC1;APOA4;...
|
| Shigellosis |
1.25 |
5.76e-1 |
180/246 (73.17%) |
TNIP1;CXCL8;CAPN2;...
|
| Type II diabetes mellitus |
1.25 |
5.63e-1 |
42/46 (91.3%) |
HK2;INSR;SOCS1;...
|
| NF-kappa B signaling pathway |
1.25 |
5.72e-1 |
90/104 (86.54%) |
CXCL8;PTGS2;PLCG2;...
|
| Phosphonate and phosphinate metabolism |
1.24 |
5.62e-1 |
5/6 (83.33%) |
CEPT1;PCYT2;CHPT1
|
| Viral myocarditis |
1.23 |
5.77e-1 |
53/60 (88.33%) |
BID;HLA-DQA1;CD55;...
|
| Huntington disease |
-1.42 |
1.51e-1 |
233/306 (76.14%) |
PLCB1;ACTR1A;NDUFA7;...
|
| Pentose and glucuronate interconversions |
-1.42 |
1.50e-1 |
17/34 (50%) |
XYLB;KL;UGP2;...
|
| Aldosterone-regulated sodium reabsorption |
-1.48 |
1.42e-1 |
34/37 (91.89%) |
ATP1B4;SCNN1A;ATP1B3;...
|
| Folate biosynthesis |
-1.48 |
1.44e-1 |
23/26 (88.46%) |
AKR1B10;AKR1B1;GCH1;...
|
| Prion disease |
-1.49 |
1.34e-1 |
209/273 (76.56%) |
NDUFA10;COX5B;PSMA3;...
|
| Pyruvate metabolism |
-1.50 |
1.28e-1 |
41/47 (87.23%) |
PC;GLO1;LDHA;...
|
| Dilated cardiomyopathy |
-1.51 |
1.23e-1 |
86/96 (89.58%) |
SGCG;CACNA2D2;AGT;...
|
| Relaxin signaling pathway |
-1.52 |
1.19e-1 |
114/129 (88.37%) |
MAP2K4;ATF6B;GNG5;...
|
| PPAR signaling pathway |
-1.53 |
1.08e-1 |
66/74 (89.19%) |
ACADM;PLIN1;RXRA;...
|
| Aminoacyl-tRNA biosynthesis |
-1.54 |
1.12e-1 |
15/66 (22.73%) |
SARS2;TARS2;GATB;...
|
| AMPK signaling pathway |
-1.55 |
1.09e-1 |
106/120 (88.33%) |
PIK3R3;ACACB;RAB8A;...
|
| Hypertrophic cardiomyopathy |
-1.56 |
9.87e-2 |
81/90 (90%) |
PRKAB2;ITGA1;MYL3;...
|
| Oxidative phosphorylation |
-1.57 |
9.81e-2 |
93/133 (69.92%) |
PPA2;ATP6V1B1;NDUFA7;...
|
| Propanoate metabolism |
-1.57 |
1.02e-1 |
30/34 (88.24%) |
LDHA;BCKDHA;ECHS1;...
|
| AGE-RAGE signaling pathway in diabetic complications |
-1.61 |
7.52e-2 |
97/100 (97%) |
NOX4;STAT1;NOX1;...
|
| Malaria |
-1.61 |
7.50e-2 |
44/50 (88%) |
GYPA;HGF;SELE;...
|
| Tryptophan metabolism |
-1.62 |
7.41e-2 |
35/42 (83.33%) |
ALDH3A2;DDC;DLST;...
|
| Fatty acid elongation |
-1.62 |
7.89e-2 |
19/27 (70.37%) |
ELOVL5;ACOT7;ACAA2;...
|
| Biosynthesis of unsaturated fatty acids |
-1.63 |
8.37e-2 |
21/27 (77.78%) |
FADS1;ELOVL4;SCD5;...
|
| Terpenoid backbone biosynthesis |
-1.63 |
8.62e-2 |
18/22 (81.82%) |
PCYOX1;FNTB;FDPS;...
|
| Melanoma |
-1.66 |
7.61e-2 |
68/72 (94.44%) |
MET;FGF1;RAF1;...
|
| Glyoxylate and dicarboxylate metabolism |
-1.66 |
8.09e-2 |
23/30 (76.67%) |
HAO2;AGXT;CAT;...
|
| Cysteine and methionine metabolism |
-1.67 |
8.83e-2 |
43/50 (86%) |
TST;ADI1;CDO1;...
|
| Complement and coagulation cascades |
-1.68 |
8.35e-2 |
76/85 (89.41%) |
CFHR2;C1QA;F2R;...
|
| Cardiac muscle contraction |
-1.69 |
8.83e-2 |
64/87 (73.56%) |
TRDN;MYL3;MYL4;...
|
| Citrate cycle (TCA cycle) |
-1.69 |
1.06e-1 |
30/30 (100%) |
DLST;ACO2;IDH1;...
|
| Arginine and proline metabolism |
-1.70 |
1.19e-1 |
39/50 (78%) |
GAMT;NOS2;PRODH;...
|
| TGF-beta signaling pathway |
-1.78 |
7.72e-2 |
81/94 (86.17%) |
SMAD5;BMP5;E2F5;...
|
| Valine, leucine and isoleucine degradation |
-1.79 |
7.17e-2 |
42/48 (87.5%) |
PCCA;HMGCS2;ACAA2;...
|
| Diabetic cardiomyopathy |
-1.80 |
1.43e-1 |
162/203 (79.8%) |
SP1;NDUFA9;NDUFS4;...
|
